Copaxone Sales Data

Rank 10 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Copaxone U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 10 -4.69% -5.16%
Q3 2013 10 (1) -4.29% -6.58%
Q2 2013 9 0.79% -0.44%
Q1 2013 9 1.98% -8.03%
Q4 2012 9 3.47% 0.81%
Q3 2012 9 (4) 9.93% 9.78%
Q2 2012 13 (3) 6.65% 6.13%
Q1 2012 16 4.59% -7.42%
Q4 2011 16 (1) 0.98% 0.88%
Q3 2011 17 (2) -1.66% -0.44%
Q2 2011 19 (3) 0.29%
Q1 2011 16

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
January 30, 2014Monthly News Roundup - January 2014
July 29, 2013Court overturns patents on Teva's MS drug Copaxone
Hide
(web3)